Does spinal dexmedetomidine aggravate hypotension after tourniquet deflation?

Is spinal dexmedetomidine aggravating hypotension after tourniquet deflation?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201703002085343

Enrollment

Registered

2017-03-09

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tourniquet hypotension

Interventions

DBupi

dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA ¿ ¿ II. Patients scheduled for elective knee arthroscopy under spinal anesthesia

Exclusion criteria

Exclusion criteria: ¿ Increased intracranial pressure. ¿ Hemorrhagic diathesis. ¿ Infection at the puncture site. ¿ Neurological disorder.

Design outcomes

Primary

Measure	Time frame
evaluate the effect of intrathecal dexemetomedine in hemodynamics after tourniquet deflation in knee arthroscopy.	—

Secondary

Measure	Time frame
evaluate efficacy of addition dexemetomedine in spinal anesthesia in decreasing incidence of tourniquet pain.	—

Countries

Egypt

Contacts

Public ContactAhmed Farid

01002356222fareed@gmail.com00201002356222

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026